netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Ponatinib found 4 matches

Open monograph to display formulary status BNF Category
  Ponatinib  (Iclusig®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (April 2017): Ponatinib  (Iclusig▼): risk of vascular occlusive events—updated advice on possible dose reduction (08.01.05)
link in drug section MHRA Drug Safety Update (October 2018): Ponatinib (Iclusig▼): reports of posterior reversible encephalopathy syndrome (08.01.05)
link in drug section NICE TA451 Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia (08.01.05)


 

netFormulary